FDA Seeks Comments on Entry Data Requirements

The Food and Drug Administration seeks comments on its data requirements for imports and electronic entries as it submits them to the Office of Management and Budget for reapproval, FDA said in a notice. The agency seeks comments on the necessity of its ACE filing requirements, their burden on importers and exporters, and ways to improve the information collection. FDA is revising its OMB approval request to add information collected via its weekly entry filing program for foreign-trade zones, as well as information collected by way of the agency's Import Trade Auxiliary Communication System. Comments are due March 3.